Category: News Well
Content tagged to appear in the middle column of the home page
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
The U.S. Defense Dept. agrees to pay Meridian Medical Technologies $130 million to develop auto-injectors that can deliver nerve agent antidotes.
Maryland's Meridian Medical Technologies is moving ahead with a whopping $129.5 million U.S. government contract to develop auto-injectors that can deliver nerve agent antidotes.
The FDA grants 510(k) clearance for Bio2 Technologies' CLM bioactive scaffold wedges.
Massachusetts startup Bio2 Technologies plans a limited rollout in 2015 of its high-tech bioactive bone scaffold wedges, following the FDA's recent 510(k) clearance of the product.
The Centers for Medicare & Medicaid Services will officially remove national coverage decisions for 7 procedures under a program initiated in November 2013, including stereotactic cingulotomy, tinnitus masking and more.
The Centers for Medicare & Medicaid Services are removing national coverage decisions for 7 medical procedures, including certain types of lobotomies and tinnitus masking devices, after a year-long review initiated in November 2013.
Zimmer is off the hook for the triple damages it owed Stryker after a patent infringement loss last year.
Medtronic says it's done with a global user evaluation of a new closed-loop insulin pump with predictive low glucose management technology.
Medtronic (NYSE:MDT) said today that it's done with a global user evaluation program for a next-generation insulin pump system as it pursues the Holy Grail of diabetes: The artificial pancreas.
The FDA reportedly grounds an internal feasibility study of using unmanned drones in facility inspections.
An FDA proposal to test unmanned drones in facility inspections was grounded before it could take flight, according to a report in Regulatory Focus.
An internal FDA memo obtained by the publication revealed that the agency was planning to "perform a test of drone technology" sometime this week.